pharma news today glp-1 obesity What is the pipeline for future medications for obesity? The GLP-1 Access Gap: Mapping

For the latest news, weather, sports, and streaming video, head to The Hill.

Moreover, GLP-1-based therapies were also associated with significant reductions in total cholesterol, LDL-cholesterol and triglycerides

As predicted by trRosetta, the fusion of HSA-binding DARPin to GLP-1 using a rigid helical linker does not alter the tertiary structure of the fusion partner, and each moiety of the fusion proteins will most likely retain their conformational properties and relevant biological functions as the native protein

Key findings (Rodriguez et al., 2023) include: HbA1c reductions of up to 2.1% in 36 weeks

If you're considering options for weight or metabolic health, talk with your healthcare provider

Until now the tests with exendin-4 had only been done in mice and the company was unsure what would happen when it was given to humans